Email address
[email protected]Contact number
+49 30 203 60 0About
Provided by CMS
The CMS Life Sciences und Healthcare Sector Group is made up of over 50 lawyers across Europe, many of whom have specialised in the Life Sciences und Healthcare industry for several years.
The essence of the group's approach is teamwork, working closely as colleagues in Western and Central Europe. The group has complementary expertise in pharmaceutical, biotechnology, medical device, diagnostic and related areas, so can offer pan-European and local, national advice and assistance to the Life Sciences und Healthcare industries.
Please visit our website for more details about our work in this category:
https://cms.law/en/deu/global-reach/europe/germany/expertise/life-sciences-healthcare
Chambers Review
CMS has a well-regarded life sciences practice recognised for its abilities in product liability mandates, including assistance with product recall matters and disputes. It additionally advises on a range of commercial contracts, including marketing, research and licensing agreements, both on a national and international scale. The team mainly works for pharmaceutical and medical device corporations. It also handles drug classification issues as well as regulatory issues in the healthtech sector and offers knowledge on reimbursement matters.
Work Highlights
- CMS represented global pharmaceutical company PharmaEssentia Corporation in a dispute relating to a licensing agreement with an Austrian pharma company.
Strengths
Provided by Chambers
"The team offers a very strong performance."
"CMS provides proactive communication on upcoming steps, keeping us well informed."
"CMS has a good and renowned practice, which is also quite visible in the market."
"The team offers a very strong performance."
"CMS provides proactive communication on upcoming steps, keeping us well informed."
"CMS has a good and renowned practice, which is also quite visible in the market."
Notable Practitioners
Jens Wagner is noted for advising international pharmaceutical, medical device and biotech companies on regulatory compliance, product liability and voluntary recalls. He has additional strength in intellectual property and advertising disputes.
"We value him both as a tough litigator and as a very competent adviser and negotiator. Due to his excellent industry expertise and team orientation, he is able to build a powerful life sciences team around the younger partners and counsel."
"He demonstrates experience and a strategic approach."